Skip to main content
logo
Tinavi Medical Technologies Co., Ltd. (SHA:688277)
China flag China · Delayed Price · Currency is CNY
15.02
-0.47 (-3.03%)
Sep 14, 2026, 3:00 PM CST

SHA:688277 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
258.77278.82178.84210.04156.19156.02
Revenue Growth
5.26%55.90%-14.85%34.48%0.11%14.80%
Gross Profit
170.74192.17124.66138.92102.17105.98
Operating Income
-215.63-179.41-157.73-211.6-174.87-140.86
Net Income
-195.31-182.75-121.13-156.39-110.58-79.93
Earnings Per Share
-0.42-0.40-0.27-0.35-0.26-0.19
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
245.74305.8286.79360.9251.59407.74
Total Debt
189.32197.09198.54219.8998.4270.76
Net Cash (Debt)
56.42108.7188.25141.01153.17336.98
Net Cash Growth
-49.55%23.18%-37.42%-7.94%-54.55%-53.24%
Net Cash Per Share
0.120.240.200.320.360.80

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-130.59-51.17-98.65-170.5-87.51-77.76
Capital Expenditures
-27.27-29.71-36.69-221.03-59.59-238.66
Free Cash Flow
-157.86-80.88-135.34-391.53-147.1-316.42
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
65.98%68.92%69.70%66.14%65.42%67.93%
Operating Margin
-83.33%-64.35%-88.20%-100.74%-111.96%-90.28%
Pretax Margin
-65.69%-55.48%-55.66%-71.74%-92.30%-67.08%
Profit Margin
-75.47%-65.54%-67.73%-74.46%-70.80%-51.23%
FCF Margin
-61.00%-29.01%-75.68%-186.41%-94.18%-202.80%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
27.0724.8425.1028.2031.9670.64